\begin{table}[htbp]
\centering
\tiny
\caption{Feature comparison between positive and negative DDI samples using permutation tests.}
\label{tab:ddi_feature_comparison}
\begin{tabular}{lllllll}
\toprule
Feature & \multicolumn{2}{c}{Positive} & \multicolumn{2}{c}{Negative} & $p$-value & Cohen's $d$ \\
\cmidrule(lr){2-3} \cmidrule(lr){4-5}
 & mean$\pm$std & median & mean$\pm$std & median & & \\
\midrule
SMILES Length (Drug 1) & 72.33 $\pm$ 74.12 & 55.00 & 57.57 $\pm$ 54.07 & 50.00 & $<$0.001 & 0.228 \\
SMILES Length (Drug 2) & 65.05 $\pm$ 72.16 & 50.00 & 56.99 $\pm$ 50.45 & 50.00 & 1.000 & 0.129 \\
Total SMILES Length & 137.37 $\pm$ 105.21 & 112.00 & 114.56 $\pm$ 73.39 & 102.00 & $<$0.001 & 0.252 \\
Target Genes (Drug 1) & 4.12 $\pm$ 7.16 & 2.00 & 2.75 $\pm$ 7.38 & 1.00 & $<$0.001 & 0.188 \\
Target Genes (Drug 2) & 5.25 $\pm$ 8.16 & 2.00 & 2.80 $\pm$ 7.73 & 1.00 & $<$0.001 & 0.308 \\
Total Target Genes & 9.37 $\pm$ 10.86 & 6.00 & 5.56 $\pm$ 10.67 & 3.00 & $<$0.001 & 0.354 \\
\bottomrule
\end{tabular}
\vspace{2mm}

{\footnotesize
\textit{Note}: Statistical significance assessed using two-tailed permutation tests (10,000 permutations), which remain valid at the pair level despite drug-level redundancy (mean 14.4 appearances per drug). $p$-values are Bonferroni-corrected ($\alpha = 0.008333$) for 6 comparisons. Medians provided due to highly skewed distributions (CV $>$ 100\%).
}
\end{table}
